Variation of 46 Innate Immune Genes Evaluated for their Contribution in Pneumococcal Meningitis Susceptibility and Outcome

• Main Authors: Bart Ferwerda, Mercedes Valls Serón, Aldo Jongejan, Aeilko H. Zwinderman, Madelijn Geldhoff, Arie van der Ende, Frank Baas, Matthijs C. Brouwer, Diederik van de Beek
• Format: Article
• Language: English
• Published: Elsevier 2016-08-01
• Series: EBioMedicine
• Subjects: Innate immunity; Pneumococcal meningitis; IRAK4; NOD2
• Online Access: http://www.sciencedirect.com/science/article/pii/S2352396416303164

Pneumococcal meningitis is the most common and severe form of bacterial meningitis. Early recognition of the pathogen and subsequent innate immune response play a vital role in disease susceptibility and outcome. Genetic variations in innate immune genes can alter the immune response and influence susceptibility and outcome of meningitis disease. Here we conducted a sequencing study of coding regions from 46 innate immune genes in 435 pneumococcal meningitis patients and 416 controls, to determine the role of genetic variation on pneumococcal meningitis susceptibility and disease outcome. Strongest signals for susceptibility were rs56078309 CXCL1 (p = 4.8e−04) and rs2008521 in CARD8 (p = 6.1e−04). For meningitis outcome the rs2067085 in NOD2 (p = 5.1e−04) and rs4251552 of IRAK4 were the strongest associations with unfavorable outcome (p = 6.7e−04). Haplotype analysis showed a haplotype block, determined by IRAK4 rs4251552, significantly associated with unfavorable outcome (p = 0.004). Cytokine measurements from cerebrospinal fluid showed that with the IRAK4 rs4251552 G risk allele had higher levels of IL-6 compared to individuals with A/A genotype (p = 0.04). We show that genetic variation within exons and flanking regions of 46 innate immunity genes does not yield significant association with pneumococcal meningitis. The strongest identified signal IRAK4 does imply a potential role of genetic variation in pneumococcal meningitis.